These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30511199)

  • 1. Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Piñero F; Rubinstein F; Marciano S; Fernández N; Silva J; Zambelo Y; Anders M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Silva M
    Dig Dis Sci; 2019 Mar; 64(3):718-728. PubMed ID: 30511199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis.
    Chaiteerakij R; Chattieng P; Choi J; Pinchareon N; Thanapirom K; Geratikornsupuk N
    Ann Hepatol; 2017; 16(3):421-429. PubMed ID: 28425412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
    Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
    World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
    Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
    BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of ultrasound surveillance for hepatocellular carcinoma in a Canadian centre and determinants of its success.
    Khalili K; Menezes R; Kim TK; Kochak Yazdi L; Jang HJ; Sharma S; Feld J; Sherman M
    Can J Gastroenterol Hepatol; 2015; 29(5):267-73. PubMed ID: 26076226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of Nonsurveillance and Advanced Hepatocellular Carcinoma at Diagnosis in Chronic Liver Disease.
    Huang Y; Wallace MC; Adams LA; MacQuillan G; Garas G; Ferguson J; Samuelson S; Tibballs J; Jeffrey GP
    J Clin Gastroenterol; 2018 Jul; 52(6):551-556. PubMed ID: 28858944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma surveillance with liver imaging is not associated with improved survival.
    Lang S; Martin A; Kasper P; Schramm C; Kütting F; Goeser T; Steffen HM; Demir M
    Scand J Gastroenterol; 2020 Feb; 55(2):222-227. PubMed ID: 31990240
    [No Abstract]   [Full Text] [Related]  

  • 8. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for early diagnosis of hepatocellular carcinoma: how best to do it?
    Giannini EG; Cucchetti A; Erroi V; Garuti F; Odaldi F; Trevisani F
    World J Gastroenterol; 2013 Dec; 19(47):8808-21. PubMed ID: 24379604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A training program for primary care physicians improves the effectiveness of ultrasound surveillance of hepatocellular carcinoma.
    Del Poggio P; Olmi S; Ciccarese F; Mazzoleni M; Jazzetti M; Jamoletti C; Mattiello M; Del Poggio A; Portugali V; Stroffolini T
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1103-8. PubMed ID: 26049705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
    Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study.
    Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1795-1803. PubMed ID: 32222111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
    Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
    Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.
    Prapruttam D; Suksai J; Kitiyakara T; Phongkitkarun S
    J Med Assoc Thai; 2014 Nov; 97(11):1199-208. PubMed ID: 25675686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
    Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
    J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma.
    Piñero F; Tanno M; Aballay Soteras G; Tisi Baña M; Dirchwolf M; Fassio E; Ruf A; Mengarelli S; Borzi S; Fernández N; Ridruejo E; Descalzi V; Anders M; Mazzolini G; Reggiardo V; Marciano S; Perazzo F; Spina JC; McCormack L; Maraschio M; Lagues C; Gadano A; Villamil F; Silva M; Cairo F; Ameigeiras B;
    Ann Hepatol; 2020; 19(5):546-569. PubMed ID: 32593747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.